ProPhase Labs, Inc. Share-based Payment Arrangement, Expense
ProPhase Labs, Inc. (PRPH) reported Share-based Payment Arrangement, Expense of $376.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-19
- ProPhase Labs, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was -$14.00K, a 102.80% decline year-over-year.
- ProPhase Labs, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $390.00K, a 25.14% decline year-over-year.
- ProPhase Labs, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $400.00K, a 33.33% decline year-over-year.
- ProPhase Labs, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $400.00K, a 33.33% decline year-over-year.
- ProPhase Labs, Inc. share-based payment arrangement, expense for fiscal 2025 was $1.90M, a 47.22% decline from fiscal 2024.
- ProPhase Labs, Inc. share-based payment arrangement, expense for fiscal 2024 was $3.60M, a 2.86% increase from fiscal 2023.
- ProPhase Labs, Inc. share-based payment arrangement, expense for fiscal 2023 was $3.50M, a 22.22% decline from fiscal 2022.
- ProPhase Labs, Inc. share-based payment arrangement, expense for fiscal 2022 was $4.50M, a 39.79% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | $376.00K 10-Q · filed 2026-08-19 | $776.00K derived: sum of 3 quarters · filed 2026-08-19 | $1.18M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $390.00K 10-Q/A · filed 2026-07-09 | $438.00K 10-Q · filed 2026-06-30 | $790.00K derived: sum of 2 quarters · filed 2026-07-09 | $1.19M derived: sum of 3 quarters · filed 2026-07-09 | $1.69M derived: sum of 4 quarters · filed 2026-07-09 | |||
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $800.00K derived: sum of 2 quarters · filed 2026-06-01 | $1.30M derived: sum of 3 quarters · filed 2026-06-01 | $1.90M 10-K · filed 2026-06-01 | ||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-19 | $900.00K derived: sum of 2 quarters · filed 2025-11-19 | $1.50M 10-Q · filed 2025-11-19 | $2.02M derived: sum of 4 quarters · filed 2026-07-09 | ||||
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-13 | $508.00K 10-Q · filed 2026-08-19 | $1.00M 10-Q · filed 2025-08-13 | $1.62M derived: sum of 3 quarters · filed 2026-07-09 | $2.22M derived: sum of 4 quarters · filed 2026-07-09 | |||
| 2025-03-31 | $521.00K 10-Q/A · filed 2026-07-09 | $500.00K 10-Q · filed 2025-05-20 | $1.12M derived: sum of 2 quarters · filed 2026-07-09 | $1.72M derived: sum of 3 quarters · filed 2026-07-09 | $2.52M derived: sum of 4 quarters · filed 2026-07-09 | |||
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $1.20M derived: sum of 2 quarters · filed 2026-06-01 | $2.00M derived: sum of 3 quarters · filed 2026-06-01 | $3.60M 10-K · filed 2026-06-01 | ||||
| 2024-09-30 | $600.00K 10-Q · filed 2025-11-19 | $1.40M derived: sum of 2 quarters · filed 2025-11-19 | $3.00M 10-Q · filed 2025-11-19 | $3.60M derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $800.00K 10-Q · filed 2025-08-13 | $2.40M 10-Q · filed 2025-08-13 | $3.00M derived: sum of 3 quarters · filed 2025-08-13 | $3.90M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $1.60M 10-Q · filed 2025-05-20 | $2.20M derived: sum of 2 quarters · filed 2025-05-20 | $3.10M derived: sum of 3 quarters · filed 2025-05-20 | $4.20M derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $1.50M derived: sum of 2 quarters · filed 2025-04-01 | $2.60M derived: sum of 3 quarters · filed 2025-04-01 | $3.50M 10-K · filed 2025-04-01 | ||||
| 2023-09-30 | $900.00K 10-Q · filed 2024-11-13 | $700.00K 10-Q · filed 2023-11-13 | $2.00M derived: sum of 2 quarters · filed 2024-11-13 | $2.90M 10-Q · filed 2024-11-13 | $4.40M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $1.10M 10-Q · filed 2024-08-14 | $2.00M 10-Q · filed 2024-08-14 | $3.50M derived: sum of 3 quarters · filed 2024-08-14 | $5.50M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $900.00K 10-Q · filed 2024-05-10 | $2.40M derived: sum of 2 quarters · filed 2024-05-10 | $4.40M derived: sum of 3 quarters · filed 2024-05-10 | $4.90M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $3.50M derived: sum of 2 quarters · filed 2023-11-13 | $4.00M derived: sum of 3 quarters · filed 2023-11-13 | $4.50M 10-K · filed 2023-03-29 | ||||
| 2022-09-30 | $2.00M 10-Q · filed 2023-11-13 | $2.50M derived: sum of 2 quarters · filed 2023-11-13 | $3.00M 10-Q · filed 2023-11-13 | $3.78M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-11 | $1.00M 10-Q · filed 2023-08-11 | $3.82M 10-Q · filed 2022-08-12 | $1.78M derived: sum of 3 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $500.00K 10-Q · filed 2023-05-12 | $2.75M 10-Q · filed 2022-05-13 | $1.28M derived: sum of 2 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.22M 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | $2.44M 10-Q · filed 2021-11-12 | |||||||
| 2020-09-30 | $379.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $329.00K derived: sum of 2 quarters · filed 2021-11-12 | $679.00K 10-Q · filed 2021-11-12 | $669.00K 10-Q · filed 2020-11-19 | ||||
| 2020-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $300.00K 10-Q · filed 2020-08-11 | ||||||
| 2020-03-31 | $350.00K 10-Q · filed 2020-05-12 | |||||||
| 2019-12-31 | $401.00K 10-K · filed 2020-03-26 | |||||||
| 2018-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $400.00K derived: sum of 2 quarters · filed 2019-03-26 | $603.00K derived: sum of 3 quarters · filed 2019-03-26 | $634.00K 10-K · filed 2019-03-26 | ||||
| 2018-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $402.00K derived: sum of 2 quarters · filed 2018-11-14 | $433.00K 10-Q · filed 2018-11-14 | $465.00K derived: sum of 4 quarters · filed 2019-03-26 | ||||
| 2018-06-30 | $203.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-20 | $234.00K 10-Q · filed 2018-08-20 | $266.00K derived: sum of 3 quarters · filed 2019-03-26 | $294.00K derived: sum of 4 quarters · filed 2019-03-26 | ||||
| 2018-03-31 | $31.00K 10-Q/A · filed 2018-08-20 | $63.00K derived: sum of 2 quarters · filed 2019-03-26 | $91.00K derived: sum of 3 quarters · filed 2019-03-26 | |||||
| 2017-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $60.00K derived: sum of 2 quarters · filed 2019-03-26 | $78.00K 10-K · filed 2019-03-26 | |||||
| 2017-09-30 | $28.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | $46.00K 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | $18.00K 10-Q/A · filed 2018-08-20 | |||||||
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $0.00 derived: sum of 2 quarters · filed 2018-08-20 | $0.00 derived: sum of 3 quarters · filed 2018-08-20 | $1.00K 10-K/A · filed 2018-08-20 | ||||
| 2016-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | $0.00 derived: sum of 2 quarters · filed 2018-08-20 | $1.00K 10-Q/A · filed 2018-08-20 | $35.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $1.00K 10-Q/A · filed 2018-08-20 | $35.00K derived: sum of 3 quarters · filed 2018-08-20 | $68.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-03-31 | $1.00K 10-Q/A · filed 2018-08-20 | $35.00K derived: sum of 2 quarters · filed 2018-08-20 | $68.00K derived: sum of 3 quarters · filed 2018-08-20 | $102.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2015-12-31 | $34.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $67.00K derived: sum of 2 quarters · filed 2018-08-20 | $101.00K derived: sum of 3 quarters · filed 2018-08-20 | $135.00K 10-K/A · filed 2018-08-20 | ||||
| 2015-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $67.00K derived: sum of 2 quarters · filed 2016-11-14 | $101.00K 10-Q · filed 2016-11-14 | $954.00K derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $68.00K 10-Q · filed 2016-08-11 | $921.00K derived: sum of 3 quarters · filed 2017-02-24 | $984.00K derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $34.00K 10-Q · filed 2016-05-13 | $887.00K derived: sum of 2 quarters · filed 2017-02-24 | $950.00K derived: sum of 3 quarters · filed 2017-02-24 | $1.01M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $916.00K derived: sum of 2 quarters · filed 2017-02-24 | $980.00K derived: sum of 3 quarters · filed 2017-02-24 | $1.04M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $127.00K derived: sum of 2 quarters · filed 2015-11-13 | $191.00K 10-Q · filed 2015-11-13 | $314.00K derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $128.00K 10-Q · filed 2015-08-12 | $251.00K derived: sum of 3 quarters · filed 2016-03-29 | $318.00K derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $64.00K 10-Q · filed 2015-05-13 | $187.00K derived: sum of 2 quarters · filed 2016-03-29 | $254.00K derived: sum of 3 quarters · filed 2016-03-29 | $294.00K derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $190.00K derived: sum of 2 quarters · filed 2016-03-29 | $230.00K derived: sum of 3 quarters · filed 2016-03-29 | $269.00K 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $107.00K derived: sum of 2 quarters · filed 2014-11-13 | $146.00K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $79.00K 10-Q · filed 2014-08-12 | ||||||
| 2013-03-31 | $39.00K 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | $246.00K 10-K · filed 2015-03-27 | $153.00K 10-K · filed 2013-03-28 | ||||||
| 2011-12-31 | $631.00K 10-K · filed 2014-03-27 | $131.00K 10-K · filed 2013-03-28 | ||||||
| 2010-12-31 | $42.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |